Association of prospective risk for chronic PTSD symptoms with low TNFa and IFNG concentrations in the immediate aftermath of trauma exposure

American Journal of Psychiatry

Volumn 177, Issue 1, 2020, Pages 58-65

  Michopoulos, Vasiliki ^a,b   Beurel, Eleonore ^c   Gould, Felicia ^c   Dhabhar, Firdaus S ^c,d,e   Schultebraucks, Katharina ^f   Galatzer Levy, Isaac ^f   Rothbaum, Barbara O ^a   Ressler, Kerry J ^g   Nemeroff, Charles B ^h  

^a EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b EMORY UNIVERSITY   (United States)

^c UNIVERSITY OF MIAMI MILLER SCHOOL OF MEDICINE   (United States)

^d UNIVERSITY OF MIAMI   (United States)

^e University of Miami   (United States)

^f NEW YORK UNIVERSITY SCHOOL OF MEDICINE   (United States)

^g HARVARD MEDICAL SCHOOL   (United States)

^h UNIVERSITY OF TEXAS AT AUSTIN   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EOTAXIN; FIBROBLAST GROWTH FACTOR 2; GAMMA INTERFERON; GAMMA INTERFERON INDUCIBLE PROTEIN 10; GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR; INTERLEUKIN 1 RECEPTOR ASSOCIATED KINASE; INTERLEUKIN 10; INTERLEUKIN 12; INTERLEUKIN 13; INTERLEUKIN 15; INTERLEUKIN 17; INTERLEUKIN 1BETA; INTERLEUKIN 2; INTERLEUKIN 4; INTERLEUKIN 5; INTERLEUKIN 6; INTERLEUKIN 7; INTERLEUKIN 8; INTERLEUKIN 9; MACROPHAGE INFLAMMATORY PROTEIN 1ALPHA; MACROPHAGE INFLAMMATORY PROTEIN 1BETA; MONOCYTE CHEMOTACTIC PROTEIN 1; PLATELET DERIVED GROWTH FACTOR BB; RANTES; TUMOR NECROSIS FACTOR;

ADULT; AGE DISTRIBUTION; AGED; ARTICLE; BLOOD SAMPLING; BODY MASS; CLINICAL ARTICLE; DSM-IV; EMERGENCY CARE; ETHNIC DIFFERENCE; EXPOSURE TO VIOLENCE; FEMALE; FOLLOW UP; HIGH RISK PATIENT; HUMAN; IMMUNE RESPONSE; MALE; POSTTRAUMATIC STRESS DISORDER; PRIORITY JOURNAL; RISK ASSESSMENT; RISK FACTOR; SEX DIFFERENCE;

EID: 85077401184     PISSN: 0002953X     EISSN: 15357228     Source Type: Journal    
DOI: 10.1176/appi.ajp.2019.19010039     Document Type: Article

References (38)

1. American Psychiatric Association: Diagnostic and Statistical Manual of Mental Disorders, 5th ed, DSM-5. Washington, DC, American Psychiatric Association, 2013
2. Keane TM, Marx BP, Sloan DM: Post-traumatic stress disorder: definition, prevalence, and risk factors, in Post-Traumatic Stress Disorder: Basic Science and Clinical Practice. Edited by Shiromani PJ, Keane TM, LeDoux JE. New York, Humana Press, 2009, pp 1–19
3. Gates MA, Holowka DW, Vasterling JJ, et al: Posttraumatic stress disorder in veterans and military personnel: epidemiology, screening, and case recognition. Psychol Serv 2012; 9:361–382
4. Gillespie CF, Bradley B, Mercer K, et al: Trauma exposure and stress-related disorders in inner city primary care patients. Gen Hosp Psychiatry 2009; 31:505–514
5. Holbrook TL, Galarneau MR, Dye JL, et al: Morphine use after combat injury in Iraq and post-traumatic stress disorder. N Engl J Med 2010; 362:110–117
6. Rothbaum BO, Kearns MC, Reiser E, et al: Early intervention following trauma may mitigate genetic risk for PTSD in civilians: a pilot prospective emergency department study. J Clin Psychiatry 2014; 75: 1380–1387
7. Michopoulos V, Powers A, Gillespie CF, et al: Inflammation in fear- and anxiety-based disorders: PTSD, GAD, and beyond. Neuropsychopharmacology 2017; 42:254–270
8. Passos IC, Vasconcelos-Moreno MP, Costa LG, et al: Inflammatory markers in post-traumatic stress disorder: a systematic review,meta-analysis,andmeta-regression.LancetPsychiatry2015;2: 1002–1012
9. Shalev A, Benarroch F, Goltser-Dubner T, et al: Long-term immune alterations accompanying chronic posttraumatic stress disorder following exposure to suicide bomb terror incidents during childhood. Neuropsychobiology 2017; 76:130–135
10. Ogłodek EA, Szota AM, Mos DM, et al: Serum concentrations of chemokines (CCL-5 and CXCL-12), chemokine receptors (CCR-5 and CXCR-4), and IL-6 in patients with posttraumatic stress disorder and avoidant personality disorder. Pharmacol Rep 2015; 67: 1251–1258
11. Hoge EA, Brandstetter K, Moshier S, et al: Broad spectrum of cytokine abnormalities in panic disorder and posttraumatic stress disorder. Depress Anxiety 2009; 26:447–455
12. Teche SP, Rovaris DL, Aguiar BW, et al: Resilience to traumatic events related to urban violence and increased IL10 serum levels. Psychiatry Res 2017; 250:136–140
13. Guo M, Liu T, Guo JC, et al: Study on serum cytokine levels in post traumatic stress disorder patients. Asian Pac J Trop Med 2012;5: 323–325
14. Haroon E, Raison CL, Miller AH: Psychoneuroimmunology meets neuropsychopharmacology: translational implications of the impact of inflammation on behavior. Neuropsychopharmacology 2012; 37: 137–162
15. Harrison NA, Brydon L, Walker C, et al: Neural origins of human sickness in interoceptive responses to inflammation. Biol Psychiatry 2009; 66:415–422
16. Inagaki TK, Muscatell KA, Irwin MR, et al: Inflammation selectively enhances amygdala activity to socially threatening images. Neuroimage 2012; 59:3222–3226
17. Harrison NA, Brydon L, Walker C, et al: Inflammation causes mood changes through alterations in subgenual cingulate activity and mesolimbic connectivity. Biol Psychiatry 2009; 66:407–414
18. Eraly SA, Nievergelt CM, Maihofer AX, et al: Assessment of plasma C-reactive protein as a biomarker of posttraumatic stress disorder risk. JAMA Psychiatry 2014; 71:423–431
19. American Psychiatric Association: Diagnostic and Statistical Manual of Mental Disorders, 4th ed, DSM-IV. Washington, DC, American Psychiatric Association, 2000
20. Harris PA, Taylor R, Thielke R, et al: Research electronic data capture (REDCap): a metadata-driven methodology and workflow process for providing translational research informatics support. J Biomed Inform 2009; 42:377–381
21. Kessler RC, Chiu WT, Demler O, et al: Prevalence, severity, and comorbidity of 12-month DSM-IV disorders in the National Comorbidity Survey Replication. Arch Gen Psychiatry 2005; 62: 617–627
22. Foa EB, Riggs DS, Dancu CV, et al: Reliability and validity of a brief instrument for assessing post-traumatic stress disorder. J Trauma Stress 1993; 6:459–473
23. Thompson NJ, Fiorillo D, Rothbaum BO, et al: Coping strategies as mediators in relation to resilience and posttraumatic stress disorder. J Affect Disord 2018; 225:153–159
24. Yehuda R, Boisoneau D, Lowy MT, et al: Dose-response changes in plasma cortisol and lymphocyte glucocorticoid receptors following dexamethasone administration in combat veterans with and without posttraumatic stress disorder. Arch Gen Psychiatry 1995; 52:583–593
25. Michopoulos V, Rothbaum AO, Jovanovic T, et al: Association of CRP genetic variation and CRP level with elevated PTSD symptoms and physiological responses in a civilian population with high levels of trauma. Am J Psychiatry 2015; 172:353–362
26. Lindqvist D, Dhabhar FS, Mellon SH, et al: Increased proinflammatory milieu in combat related PTSD: a new cohort replication study. Brain Behav Immun 2017; 59:260–264
27. von Känel R, Hepp U, Kraemer B, et al: Evidence for low-grade systemic proinflammatory activity in patients with posttraumatic stress disorder. J Psychiatr Res 2007; 41:744–752
28. Bierhaus A, Wolf J, Andrassy M, et al: A mechanism converting psychosocial stress into mononuclear cell activation. Proc Natl Acad Sci USA 2003; 100:1920–1925
29. Resnick HS, Yehuda R, Pitman RK, et al: Effect of previous trauma on acute plasma cortisol level following rape. Am J Psychiatry 1995; 152:1675–1677
30. Thoma MV, Gianferante D, Hanlin L, et al: Stronger hypothalamus-pituitary-adrenal axis habituation predicts lesser sensitization of inflammatory response to repeated acute stress exposures in healthy young adults. Brain Behav Immun 2017; 61:228–235
31. Chen X, Gianferante D, Hanlin L, et al: HPA-axis and inflammatory reactivity to acute stress is related with basal HPA-axis activity. Psychoneuroendocrinology 2017; 78:168–176
32. McInnis CM, Wang D, Gianferante D, et al: Response and habituation of pro- and anti-inflammatory gene expression to repeated acute stress. Brain Behav Immun 2015; 46:237–248
33. Cohen H, Ziv Y, Cardon M, et al: Maladaptation to mental stress mitigated by the adaptive immune system via depletion of naturally occurring regulatory CD4+CD25+ cells. J Neurobiol 2006; 66: 552–563
34. Lewitus GM, Cohen H, Schwartz M: Reducing post-traumatic anxiety by immunization. Brain Behav Immun 2008; 22:1108–1114
35. Raison CL, Rutherford RE, Woolwine BJ, et al: A randomized controlled trial of the tumor necrosis factor antagonist infliximab for treatment-resistant depression: the role of baseline inflammatory biomarkers. JAMA Psychiatry 2013; 70:31–41
36. Nowotny B, Cavka M, Herder C, et al: Effects of acute psychological stress on glucose metabolism and subclinical inflammation in patients with post-traumatic stress disorder. Horm Metab Res 2010; 42: 746–753
37. Spencer-Segal JL, Hyzy RC, Iwashyna TJ, et al: Psychiatric symptoms in survivors of acute respiratory distress syndrome: effects of age, sex, and immune modulation. Ann Am Thorac Soc 2017; 14: 960–967
38. Syed SA, Beurel E, Loewenstein DA, et al: Defective inflammatory pathways in never-treated depressed patients are associated with poor treatment response. Neuron 2018; 99:914–924.e3, e913